# Inhibikase Therapeutics, Inc. (IKT)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/IKT/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -49.41M | $ -28.91M | $ 0 | $ 172.90M |
| 2024 | $ 0 | $ -28.93M | $ -20.13M | $ 110.5K | $ 94.87M |
| 2023 | $ 281.7K | $ -20.58M | $ -19.57M | $ 622.0K | $ 10.98M |
| 2022 | $ 137.9K | $ -20.17M | $ -19.65M | $ 351.3K | $ 21.04M |
| 2021 | $ 3.69M | $ -17.58M | $ -16.99M | $ 248.9K | $ 38.42M |
| 2020 | $ 889.8K | $ -3.63M | $ -1.45M | $ 319.0K | $ 9.78M |
| 2019 | $ 1.45M | $ -7.39M | $ -436.6K | $ 373.8K | $ -4.49M |
| 2018 | $ 2.69M | $ -1.84M | $ 84.5K | $ 233.7K | $ -778.0K |
| 2017 | $ 1.41M | $ -190.0K | $ 126.8K | $ 460.0K | $ -1.44M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.05 |
| Current Ratio | 21.70 |

## Other views

- [Metrics](https://sponda.capital/en/IKT.md)
- [Charts](https://sponda.capital/en/IKT/charts.md)
- [Compare](https://sponda.capital/en/IKT/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.